The global cardiac shock treatment market sales is expected to increase at a compound annual growth rate (CAGR) of 7% between 2023 and 2033, from US$ 0.9 billion in 2023 to US$ 1.77 billion by 2033. With a 3.5% compound annual growth rate, the market for cardiogenic shock treatment grew between 2018 and 2022. Cardiogenic …